tiprankstipranks
Fulgent Genetics Inc (FLGT)
NASDAQ:FLGT

Fulgent Genetics Stock Analysis & Ratings

FLGT Stock Chart & Stats

Day’s Range$51.73 - $54.47
52-Week Range$47.65 - $112.00
Previous Close$51.6
Volume347.20K
Average Volume (3M)441.06K
Market Cap$1.65B
P/E Ratio3.7
Beta1.56
Next EarningsAug 08, 2022
Next Dividend Ex-DateN/A
Dividend YieldN/A
Smart Score5
EPS (TTM)14.79


Financials

Yearly

P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

---

Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.

---

FLGT FAQ

What was Fulgent Genetics’s price range in the past 12 months?
Fulgent Genetics lowest stock price was $47.65 and its highest was $112.00 in the past 12 months.
    What is Fulgent Genetics’s market cap?
    Fulgent Genetics’s market cap is $1.65B.
      What is Fulgent Genetics’s price target?
      The average price target for Fulgent Genetics is $70.00. This is based on 1 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
      The highest analyst price target is $70.00 ,the lowest forecast is $70.00. The average price target represents 28.56% Increase from the current price of $54.45.
        What do analysts say about Fulgent Genetics?
        Fulgent Genetics’s analyst rating consensus is a ‘Moderate Buy. This is based on the ratings of 1 Wall Streets Analysts.
          When is Fulgent Genetics’s upcoming earnings report date?
          Fulgent Genetics’s upcoming earnings report date is Aug 08, 2022 which is in 84 days.
            How were Fulgent Genetics’s earnings last quarter?
            Fulgent Genetics released its earnings results on May 03, 2022. The company reported $5.08 earnings per share for the quarter, beating the consensus estimate of $3.86 by $1.22.
              Is Fulgent Genetics overvalued?
              According to Wall Street analysts Fulgent Genetics’s price is currently Undervalued.
                Does Fulgent Genetics pay dividends?
                Fulgent Genetics does not currently pay dividends.
                What is Fulgent Genetics’s EPS estimate?
                Fulgent Genetics’s EPS estimate for its next earnings report is not yet available.
                How many shares outstanding does Fulgent Genetics have?
                Fulgent Genetics has 30,330,000 shares outstanding.
                  What happened to Fulgent Genetics’s price movement after its last earnings report?
                  Fulgent Genetics reported an EPS of $5.08 in its last earnings report, beating expectations of $3.86. Following the earnings report the stock price went up 3.599%.
                    Which hedge fund is a major shareholder of Fulgent Genetics?
                    Among the largest hedge funds holding Fulgent Genetics’s share is Royce & Associates LLC. It holds Fulgent Genetics’s shares valued at 4M.

                      ---

                      Fulgent Genetics Stock Analysis

                      The Fulgent Genetics stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                      Learn more about TipRanks Smart Score

                      Company Description

                      Fulgent Genetics Inc

                      Fulgent Genetics, Inc. is a technology company, which focus on offering comprehensive genetic testing to provide physicians with clinically actionable diagnostic information they can use to improve the overall quality of patient care. Its technology platform includes proprietary gene probes, advanced database algorithms, adaptive learning software, and proprietary laboratory information management systems. The company was founded on May 13, 2016 and is headquartered in Temple City, CA.

                      ---
                      Similar Stocks
                      Company
                      Price & Change
                      Follow
                      Myriad Genetics
                      Aspira Women's Health

                      Popular Stocks

                      ---
                      What's Included in PREMIUM?
                      Make informed decisions based on Top Analysts' activity
                      Know what industry insiders are buying
                      Get actionable alerts from top Wall Street Analysts
                      Find out before anyone else which stock is going to shoot up
                      Get powerful stock screeners & detailed portfolio analysis